APA (7th ed.) Citation
(2026). Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. PLOS ONE.
Chicago Style (17th ed.) Citation
"Disproportionality Analysis of Fondaparinux Associated Adverse Events Based on the FDA Adverse Event Reporting System." PLOS ONE 2026.
MLA (9th ed.) Citation
"Disproportionality Analysis of Fondaparinux Associated Adverse Events Based on the FDA Adverse Event Reporting System." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.